Please use this identifier to cite or link to this item: https://repository.monashhealth.org/monashhealthjspui/handle/1/50758
Conference/Presentation Title: Borderline ovarian tumour audit at an Australian tertiary centre.
Authors: Mcbain R.;Kashyap A.;Vicario E.;Volchek M.;Neesham D.;Naaman Y.;Jones A. ;Rajadevan N.;Mcnally O.
Monash Health Department(s): Obstetrics and Gynaecology (Monash Women's)
Institution: (Mcbain) Royal Women's Hospital, Gynae Oncology, Parkville, Australia
(Kashyap) Monash Medical Centre, Obstetrics and Gynaecology, Clayton, Australia
(Vicario, Volchek, Neesham, Naaman, Jones, Rajadevan) Royal Women's Hospital, Gynaecological Oncology, Parkville, Australia
(Rajadevan) Peter MacCallum Cancer Centre, Laboratory Research, Melbourne, Australia
(Mcnally) Royal Women's Hospital, Gynaeoncology and Dysplasia Unit, Melbourne, Australia
(Mcnally) University of Melbourne, Department of Obstetrics and Gynaecology, Parkville, Australia
Presentation/Conference Date: 2-Jan-2024
Copyright year: 2023
Publisher: BMJ Publishing Group
Publication information: International Journal of Gynecological Cancer. Conference: International Gynecologic Cancer Society Annual Meeting, IGCS 2023. Seoul South Korea. 33(Supplement 4) (pp A195-A196), 2023. Date of Publication: November 2023.
Journal: International Journal of Gynecological Cancer
Abstract: Introduction Borderline ovarian tumors represent 10-20% of all epithelial ovarian tumors and one third of patients present younger than 40. We present an updated audit at the Royal Womens' Hospital, reviewing all cases since 1982, with particular focus on outcomes in patients who undergo fertility preserving management; rates, timing and detection of recurrence; duration and frequency of follow-up and rates of progression to cancer. Methods Single (tertiary) instituion retrospective audit Data were collected from the GEMMA and EPIC databases. Archived pathology reports were re-reviewed in cases where recurrence occured. Ethics approval was obtained AQA21/15. Results Mean age at diagnosis was 46. Correlation of frozen section results to final pathology was correct or at least queried in 109/151 cases (72%), 54 (62%) in MBOT and 55 (92%) in SBOT. Conclusion/Implications Our work contributes to existing published data. (Table Presented).
Conference Name: International Gynecologic Cancer Society Annual Meeting, IGCS 2023
Conference Start Date: 2023-11-05
Conference End Date: 2023-11-07
Conference Location: Seoul, South Korea
DOI: http://monash.idm.oclc.org/login?url=https://dx.doi.org/10.1136/ijgc-2023-IGCS.353
URI: https://repository.monashhealth.org/monashhealthjspui/handle/1/50758
Type: Conference Abstract
Subjects: ovary tumor
Appears in Collections:Conferences

Show full item record

Page view(s)

36
checked on May 1, 2025

Google ScholarTM

Check


Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.